comparemela.com

Latest Breaking News On - Peptide discovery platform system - Page 1 : comparemela.com

Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2 8bn

Novartis and PeptiDream expand peptide discovery collaboration in deal worth over $2 8bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Patrick reidPeptide discovery platform system

PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis

PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Patrickc reidTokyo stock exchange prime marketProduct servicePeptidream incGlobal head of oncology research at novartisDream announces expansionPeptide discovery collaborationDream incSwiss based novartis pharmaPeptide discovery platform systemShiva malekGlobal headOncology researchHart scott rodino antitrust improvements act

Genentech and PeptiDream to co-develop radiopharmaceuticals in $1BN deal

The Roche-owned U.S. giant Genentech has teamed up with the Japanese biotech Peptidream to co-develop peptide-based radiopharmaceutical treatments.

Patrick reidFusion pharmaceuticalsPeptide discovery platform systemOno pharmaceuticalMarkets amp regulationsEmerging markets

PeptiDream Collaborates With Genentech For Discovery And Development Of Peptide-RI Drug Conjugates

(RTTNews) - Japan-based biopharmaceutical company PeptiDream Inc. said that it has collaborated with U.S.-based Genentech, a member of the Roche.

Peptidream incRoche groupPeptide discovery platform system

PeptiDream Announces Collaboration and License Agreement with Genentech for the Discovery and Development of Novel Peptide-Radioisotope Drug Conjugates

KAWASAKI, Japan (BUSINESS WIRE) Sep 19, 2023

United statesYuko okimotoPatrickc reidPeptidream incIr public affairsTokyo stock exchange prime sectionRoche groupDream incPeptide discovery platform systemBusiness wire

vimarsana © 2020. All Rights Reserved.